Sarcopenia, muscle weakness, decrease of muscle strength. Muscle wasting and atrophy ,not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Daily intake of one magnesium supplement (250 mg) and weekly intake of vitamin D (50000 IU) for 8 weeks (2 months). Intervention 2: Control group: Daily intake of
Sponsors
personal (expenses will payed by student)
Eligibility
Sex/Gender
Female
Age
40 Years to 55 Years
Inclusion criteria
Inclusion criteria: Voluntary participation Age from 40 to 55 years old BMI>=25kg/m2 Having serum vitamin D less than 30 ng/ml
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of muscle strength in hand and foot. Timepoint: Before the intervention and two months later of intervention. Method of measurement: Dynamometer, Handgrip. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hs-CRP. Timepoint: Before the intervention and two months later of intervention. Method of measurement: immunoturbidimetry.;TNF-a. Timepoint: Before the intervention and two months later of intervention. Method of measurement: Concentration of TNF-a in serum using ELISA kit.;IL-6. Timepoint: Before the intervention and two months later of intervention. Method of measurement: Concentration of IL-6 in serum using ELISA kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Vafa
Iran University of Medical science
Outcome results
None listed